CAR T-Cell Therapy Combined with PD-1 Inhibitors Significantly Improve the Efficacy and Prognosis of r/r DLBCL with TP53 AlterationsBin Xue,Xiu Luo,Yifan Liu,Shiguang Ye,Lili Zhou,Shaoguang Li,Ping Li,Aibin LiangBLOOD(2023)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要